PAPER Gronek P, Balko S, Gronek J, Zajac A, Maszczyk A, Celka R, Doberska A, Czarny W, Podstawski R, Clark CC, Yu F
SEARCH RESULTS
364 RESULTS
PAPER Zhang J, Wang L, Deng X, Fei G, Jin L, Pan X, Cai L, Albano AD, Zhong C
Five-Minute Cognitive Test as A New Quick Screening of Cognitive Impairment in The Elderly.
Aging Dis. 2019 Dec;10(6):1258-1269. PubMed: 31788337PAPER Deng W, Xing C, David R, Mastroeni D, Ning M, Lo EH, Coleman PD
AmpliSeq Transcriptome of Laser Captured Neurons from Alzheimer Brain: Comparison of Single Cell Versus Neuron Pools.
Aging Dis. 2019 Dec;10(6):1146-1158. PubMed: 31788328PAPER Torres S, García-Ruiz CM, Fernandez-Checa JC
Mitochondrial Cholesterol in Alzheimer's Disease and Niemann-Pick Type C Disease.
Front Neurol. 2019;10:1168. Epub 2019 Nov 7 PubMed: 31787922PAPER Godoy PA, Ramírez-Molina O, Fuentealba J
Exploring the Role of P2X Receptors in Alzheimer's Disease.
Front Pharmacol. 2019;10:1330. Epub 2019 Nov 7 PubMed: 31787900PAPER Caselli RJ, Langlais BT, Dueck AC, Chen Y, Su Y, Locke DE, Woodruff BK, Reiman EM
Neuropsychological decline up to 20 years before incident mild cognitive impairment.
Alzheimers Dement. 2020 Mar;16(3):512-523. Epub 2020 Jan 6 PubMed: 31787561PAPER Verdaguer ES, Stafford J, Tuijt R, Orgeta V
Minor and subthreshold depressive disorders in Alzheimer's disease: A systematic review and meta-analysis of prevalence studies.
J Affect Disord. 2020 Feb 15;263:728-734. Epub 2019 Nov 11 PubMed: 31787425PAPER Kwok T, Wu Y, Lee J, Lee R, Yung CY, Choi G, Lee V, Harrison J, Lam L, Mok V
A randomized placebo-controlled trial of using B vitamins to prevent cognitive decline in older mild cognitive impairment patients.
Clin Nutr. 2019 Nov 20; PubMed: 31787369PAPER Meilandt WJ, Maloney JA, Imperio J, Lalehzadeh G, Earr T, Crowell S, Bainbridge TW, Lu Y, Ernst JA, Fuji RN, Atwal JK
Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric Aβ.
Alzheimers Res Ther. 2019 Dec 1;11(1):97. PubMed: 31787113PAPER Pérez-Grijalba V, Arbizu J, Romero J, Prieto E, Pesini P, Sarasa L, Guillen F, Monleón I, San-José I, Martínez-Lage P, Munuera J, Hernández I, Buendía M, Sotolongo-Grau O, Alegret M, Ruiz A, Tárraga L, Boada M, Sarasa M, AB255 Study Group
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study.
Alzheimers Res Ther. 2019 Dec 1;11(1):96. PubMed: 31787105PAPER Padovani A, Benussi A, Cotelli MS, Ferrari C, Cantoni V, Dell'Era V, Turrone R, Paghera B, Borroni B
Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy.
Alzheimers Res Ther. 2019 Dec 1;11(1):95. PubMed: 31787103PAPER Naparstek S, Linkovski O, O'Hara R
The Future of Dementia Biomarkers Needs Better Neuropsychology.
Am J Psychiatry. 2019 Dec 1;176(12):1050. PubMed: 31787015PAPER Wang W, Mei M, Gao Y, Huang B, Qiu Y, Zhang Y, Wang L, Zhao J, Huang Z, Wang L, Nie K
Changes of brain structural network connection in Parkinson's disease patients with mild cognitive dysfunction: a study based on diffusion tensor imaging.
J Neurol. 2020 Apr;267(4):933-943. Epub 2019 Dec 2 PubMed: 31792673PAPER Kim HG, Jung HS, Koo BH, Cheon EJ
Neuropsychological predictors of cognitive deterioration in non-demented individuals.
Cogn Neuropsychiatry. 2020 Mar;25(2):99-112. Epub 2019 Dec 2 PubMed: 31791187PAPER Dumitrascu OM, Koronyo-Hamaoui M
Retinal vessel changes in cerebrovascular disease.
Curr Opin Neurol. 2020 Feb;33(1):87-92. PubMed: 31789703Current Filters
- Date Range : Dec 2019 to Dec 2019 x